PubMed:7734850 / 1582-1763 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T11","span":{"begin":56,"end":69},"obj":"https://glytoucan.org/Structures/Glycans/G00068MO"},{"id":"T12","span":{"begin":56,"end":69},"obj":"https://glytoucan.org/Structures/Glycans/G43391VM"},{"id":"T13","span":{"begin":56,"end":69},"obj":"https://glytoucan.org/Structures/Glycans/G50899UD"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T16","span":{"begin":56,"end":69},"obj":"Glycan_Motif"}],"attributes":[{"id":"A16","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G50899UD"},{"id":"A17","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43391VM"},{"id":"A18","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00068MO"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T13","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T13","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T13","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T12","span":{"begin":56,"end":69},"obj":"https://glytoucan.org/Structures/Glycans/G00068MO"},{"id":"T13","span":{"begin":56,"end":69},"obj":"https://glytoucan.org/Structures/Glycans/G43391VM"},{"id":"T14","span":{"begin":56,"end":69},"obj":"https://glytoucan.org/Structures/Glycans/G50899UD"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T6","span":{"begin":56,"end":61},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T7","span":{"begin":56,"end":61},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T24","span":{"begin":56,"end":61},"obj":"FMAID:256053"},{"id":"_T25","span":{"begin":174,"end":180},"obj":"FMAID:256050"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"uniprot-human","denotations":[{"id":"T19","span":{"begin":17,"end":37},"obj":"http://www.uniprot.org/uniprot/Q10981"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"uniprot-mouse","denotations":[{"id":"T6","span":{"begin":17,"end":37},"obj":"http://www.uniprot.org/uniprot/Q9JL27"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T32","span":{"begin":4,"end":8},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T33","span":{"begin":4,"end":8},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T34","span":{"begin":62,"end":67},"obj":"http://purl.bioontology.org/ontology/STY/T096"},{"id":"T35","span":{"begin":148,"end":154},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"},{"id":"T36","span":{"begin":174,"end":180},"obj":"http://purl.bioontology.org/ontology/STY/T024"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GO-BP","denotations":[{"id":"T15","span":{"begin":11,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0008107"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"UBERON-AE","denotations":[{"id":"T10","span":{"begin":174,"end":180},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"T12","span":{"begin":56,"end":61},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T6","span":{"begin":56,"end":61},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T7","span":{"begin":56,"end":61},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T6","span":{"begin":56,"end":67},"obj":"http://rdf.glycoinfo.org/glycan/G00066MO"},{"id":"T7","span":{"begin":56,"end":69},"obj":"http://rdf.glycoinfo.org/glycan/G00068MO"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T289","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G93924TT\""},{"id":"GlycanIUPAC_T294","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G25565DN\""},{"id":"GlycanIUPAC_T299","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G97215EV\""},{"id":"GlycanIUPAC_T304","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G79664KO\""},{"id":"GlycanIUPAC_T309","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G24107FU\""},{"id":"GlycanIUPAC_T314","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G09864UE\""},{"id":"GlycanIUPAC_T319","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G28032MC\""},{"id":"GlycanIUPAC_T324","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G28005UP\""},{"id":"GlycanIUPAC_T329","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G92708AT\""},{"id":"GlycanIUPAC_T334","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G73757UC\""},{"id":"GlycanIUPAC_T339","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G51062DM\""},{"id":"GlycanIUPAC_T344","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G05866BJ\""},{"id":"GlycanIUPAC_T349","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G87394FZ\""},{"id":"GlycanIUPAC_T354","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G03871NF\""},{"id":"GlycanIUPAC_T359","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G29377VE\""},{"id":"GlycanIUPAC_T364","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G33457CX\""},{"id":"GlycanIUPAC_T369","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G97368GU\""},{"id":"GlycanIUPAC_T374","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G18512EL\""},{"id":"GlycanIUPAC_T379","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G41137VS\""},{"id":"GlycanIUPAC_T384","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G30521NA\""},{"id":"GlycanIUPAC_T389","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G19388CD\""},{"id":"GlycanIUPAC_T394","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G53151FU\""},{"id":"GlycanIUPAC_T399","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G27105XC\""},{"id":"GlycanIUPAC_T404","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G91210VM\""},{"id":"GlycanIUPAC_T409","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G40841DE\""},{"id":"GlycanIUPAC_T414","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G71241HP\""},{"id":"GlycanIUPAC_T419","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G84636BJ\""},{"id":"GlycanIUPAC_T424","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G47905LJ\""},{"id":"GlycanIUPAC_T429","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G39340DV\""},{"id":"GlycanIUPAC_T434","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G48801AQ\""},{"id":"GlycanIUPAC_T439","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G14573NX\""},{"id":"GlycanIUPAC_T444","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G56762TR\""},{"id":"GlycanIUPAC_T449","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G20013XO\""},{"id":"GlycanIUPAC_T454","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G39504DR\""},{"id":"GlycanIUPAC_T459","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G35218RQ\""},{"id":"GlycanIUPAC_T464","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G53048SH\""},{"id":"GlycanIUPAC_T469","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G78418IX\""},{"id":"GlycanIUPAC_T474","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G09780OD\""},{"id":"GlycanIUPAC_T479","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G56359GL\""},{"id":"GlycanIUPAC_T484","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G78941YC\""},{"id":"GlycanIUPAC_T489","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G26829FC\""},{"id":"GlycanIUPAC_T494","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G88538ZC\""},{"id":"GlycanIUPAC_T499","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G46593ZR\""},{"id":"GlycanIUPAC_T504","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G43523TH\""},{"id":"GlycanIUPAC_T509","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G36445ON\""},{"id":"GlycanIUPAC_T514","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G67363FK\""},{"id":"GlycanIUPAC_T519","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G17562KT\""},{"id":"GlycanIUPAC_T524","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G24774YJ\""},{"id":"GlycanIUPAC_T529","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G32162UO\""},{"id":"GlycanIUPAC_T534","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G89163RR\""},{"id":"GlycanIUPAC_T539","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G99522DY\""},{"id":"GlycanIUPAC_T544","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G59246IF\""},{"id":"GlycanIUPAC_T549","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G95321NT\""},{"id":"GlycanIUPAC_T554","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G17531ZI\""},{"id":"GlycanIUPAC_T559","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G54322SU\""},{"id":"GlycanIUPAC_T564","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G72010DO\""},{"id":"GlycanIUPAC_T569","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G44269EP\""},{"id":"GlycanIUPAC_T574","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G57335AD\""},{"id":"GlycanIUPAC_T579","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G60837LL\""},{"id":"GlycanIUPAC_T584","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G61929XX\""},{"id":"GlycanIUPAC_T589","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G88747RA\""},{"id":"GlycanIUPAC_T594","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G47955HA\""},{"id":"GlycanIUPAC_T599","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G60982WS\""},{"id":"GlycanIUPAC_T604","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G37035KG\""},{"id":"GlycanIUPAC_T609","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G46297FI\""},{"id":"GlycanIUPAC_T614","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G35475KI\""},{"id":"GlycanIUPAC_T619","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G29771JN\""},{"id":"GlycanIUPAC_T624","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G61285YR\""},{"id":"GlycanIUPAC_T629","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G54785MW\""},{"id":"GlycanIUPAC_T634","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G53039GT\""},{"id":"GlycanIUPAC_T639","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G00601HK\""},{"id":"GlycanIUPAC_T644","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G10485IJ\""},{"id":"GlycanIUPAC_T649","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G16393IB\""},{"id":"GlycanIUPAC_T654","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G98436FZ\""},{"id":"GlycanIUPAC_T659","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G18825IA\""},{"id":"GlycanIUPAC_T664","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G61281HQ\""},{"id":"GlycanIUPAC_T669","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G07798TI\""},{"id":"GlycanIUPAC_T674","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G55921QA\""},{"id":"GlycanIUPAC_T679","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G99066DL\""},{"id":"GlycanIUPAC_T684","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G33451PQ\""},{"id":"GlycanIUPAC_T689","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G02111XU\""},{"id":"GlycanIUPAC_T694","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G85193OM\""},{"id":"GlycanIUPAC_T699","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G89174YQ\""},{"id":"GlycanIUPAC_T704","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G28802LE\""},{"id":"GlycanIUPAC_T709","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G56061JK\""},{"id":"GlycanIUPAC_T714","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G68941BC\""},{"id":"GlycanIUPAC_T719","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G55436FC\""},{"id":"GlycanIUPAC_T724","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G24002PU\""},{"id":"GlycanIUPAC_T729","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G61387SV\""},{"id":"GlycanIUPAC_T734","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G31834HW\""},{"id":"GlycanIUPAC_T739","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G35324RT\""},{"id":"GlycanIUPAC_T744","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G34803QO\""},{"id":"GlycanIUPAC_T749","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G92898FF\""},{"id":"GlycanIUPAC_T754","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G01318VX\""},{"id":"GlycanIUPAC_T759","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G83200MX\""},{"id":"GlycanIUPAC_T764","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G56286UC\""},{"id":"GlycanIUPAC_T769","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G07304QA\""},{"id":"GlycanIUPAC_T774","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G06868OU\""},{"id":"GlycanIUPAC_T779","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G12647BS\""},{"id":"GlycanIUPAC_T784","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G51841DF\""},{"id":"GlycanIUPAC_T789","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G32122AJ\""},{"id":"GlycanIUPAC_T794","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G41125MN\""},{"id":"GlycanIUPAC_T799","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G16093XS\""},{"id":"GlycanIUPAC_T804","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G62425IX\""},{"id":"GlycanIUPAC_T809","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G15673TO\""},{"id":"GlycanIUPAC_T814","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G32857IK\""},{"id":"GlycanIUPAC_T819","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G60047CJ\""},{"id":"GlycanIUPAC_T824","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G55718ZB\""},{"id":"GlycanIUPAC_T829","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G88355ZE\""},{"id":"GlycanIUPAC_T834","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G11283PA\""},{"id":"GlycanIUPAC_T839","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G71737IZ\""},{"id":"GlycanIUPAC_T844","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G60912WZ\""},{"id":"GlycanIUPAC_T849","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G99655SO\""},{"id":"GlycanIUPAC_T854","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G10300TW\""},{"id":"GlycanIUPAC_T859","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G89509FL\""},{"id":"GlycanIUPAC_T864","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G31465TH\""},{"id":"GlycanIUPAC_T869","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G94101LU\""},{"id":"GlycanIUPAC_T874","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G38610BB\""},{"id":"GlycanIUPAC_T879","span":{"begin":0,"end":3},"obj":"\"http://rdf.glycoinfo.org/glycan/G85893UF\""}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T6","span":{"begin":174,"end":180},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T8","span":{"begin":56,"end":61},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"mondo_disease","denotations":[{"id":"T10","span":{"begin":148,"end":154},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T10","span":{"begin":148,"end":154},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0002664"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T10","span":{"begin":148,"end":154},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T9","span":{"begin":56,"end":61},"obj":"Body_part"},{"id":"T10","span":{"begin":174,"end":180},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T6","span":{"begin":56,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A7","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T13","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T13","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T13","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T13","span":{"begin":0,"end":181},"obj":"Sentence"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T9","span":{"begin":56,"end":61},"obj":"Body_part"},{"id":"T10","span":{"begin":174,"end":180},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"Anatomy-MAT","denotations":[{"id":"T6","span":{"begin":56,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A7","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}

{"project":"HP-phenotype","denotations":[{"id":"T10","span":{"begin":148,"end":154},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue."}